| Lennox-Gastaut Syndrome

Banzel vs Trokendi XR

Side-by-side clinical, coverage, and cost comparison for lennox-gastaut syndrome.
Deep comparison between: Banzel vs Trokendi Xr with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsTrokendi Xr has a higher rate of injection site reactions vs Banzel based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Trokendi Xr but not Banzel, including UnitedHealthcare
Sign up to reveal the full AI analysis
Banzel
Trokendi Xr
At A Glance
Oral
Twice daily
Sodium channel modulator
Oral
Once daily
Anticonvulsant; carbonic anhydrase inhibitor
Indications
  • Lennox-Gastaut Syndrome
  • Lennox-Gastaut Syndrome
  • Migraine Disorders
Dosing
Lennox-Gastaut Syndrome (pediatric, 1 to <17 years) Starting dose approximately 10 mg/kg/day in two divided doses; increase by 10 mg/kg every other day to maximum 45 mg/kg/day (not to exceed 3200 mg/day); administer with food.
Lennox-Gastaut Syndrome (adults, >=17 years) Starting dose 400-800 mg/day in two divided doses; increase by 400-800 mg every other day to maximum 3200 mg/day; administer with food.
Lennox-Gastaut Syndrome Adjunctive therapy: adults (>=17 years) 200-400 mg orally once daily, initiated at 25-50 mg once daily and titrated in 25-50 mg/week increments; pediatric patients 6-16 years approximately 5-9 mg/kg/day orally once daily, initiated at 25 mg/day and titrated at 1-3 mg/kg/day every 1-2 weeks, not to exceed 400 mg/day.
Migraine Disorders Preventive treatment for patients 12 years and older: 100 mg orally once daily, titrated over 4 weeks starting at 25 mg/day (Week 1: 25 mg, Week 2: 50 mg, Week 3: 75 mg, Week 4: 100 mg).
Contraindications
  • Familial Short QT syndrome
  • Recent alcohol use within 6 hours prior to or 6 hours after TROKENDI XR administration
  • History of hypersensitivity reaction to topiramate, TROKENDI XR, or any inactive ingredient (anaphylaxis and angioedema have occurred)
Adverse Reactions
Most common (>=10%) Headache, dizziness, fatigue, somnolence, nausea
Serious Suicidal behavior and ideation, CNS reactions, QT shortening, multi-organ hypersensitivity/DRESS, leukopenia
Postmarketing Stevens-Johnson syndrome and other serious skin rashes with mucosal involvement
Most common (>=10%) Paresthesia, weight loss, anorexia, dizziness, somnolence, nervousness, psychomotor slowing, speech disorders, vision abnormal
Serious Acute myopia and secondary angle closure glaucoma, metabolic acidosis, oligohydrosis and hyperthermia, suicidal behavior and ideation, fetal toxicity, DRESS/multiorgan hypersensitivity, serious skin reactions, anaphylaxis and angioedema, hyperammonemia and encephalopathy, decrease of bone mineral density, kidney stones
Postmarketing Hepatic failure, hepatitis, pancreatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, pemphigus, nephrocalcinosis, maculopathy, decreased INR with vitamin K antagonists
Pharmacology
Rufinamide is an antiepileptic triazole derivative whose principal mechanism of action is modulation of sodium channel activity, specifically prolonging the inactive state of the channel to limit sustained repetitive neuronal firing.
Topiramate is a sulfamate-substituted monosaccharide anticonvulsant whose precise mechanism is unknown but is believed to involve blockade of voltage-dependent sodium channels, augmentation of GABA-A receptor activity, antagonism of AMPA/kainate glutamate receptors, and inhibition of carbonic anhydrase isozymes II and IV.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Banzel
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (1/12) · Qty limit (0/12)
View full coverage details ›
Trokendi Xr
  • Covered on 5 commercial plans
  • PA (5/12) · Step Therapy (0/12) · Qty limit (9/12)
View full coverage details ›
UnitedHealthcare
Banzel
  • Covered on 4 commercial plans
  • PA (4/8) · Step Therapy (4/8) · Qty limit (0/8)
View full coverage details ›
Trokendi Xr
  • Covered on 4 commercial plans
  • PA (1/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Banzel
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
View full coverage details ›
Trokendi Xr
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (0/3) · Qty limit (3/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
Cost estimate not availableAssistance Fund: Epilepsy (Seizures): Waitlist
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
No savings programs available for Trokendi Xr.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
BanzelView full Banzel profile
Trokendi XrView full Trokendi Xr profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.